Semnur Pharmaceuticals, Inc. (SMNR)
0.55
0.00 (0.00%)
USD |
OTCM |
Aug 31, 16:00
Semnur Pharmaceuticals Shareholders Equity (Quarterly) : -29.67M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -29.67M |
| March 31, 2026 | -25.33M |
| December 31, 2025 | -20.75M |
| September 30, 2025 | -14.59M |
| June 30, 2025 | -10.59M |
| March 31, 2025 | -1.591M |
| December 31, 2024 | -42.78M |
| September 30, 2024 | -0.557M |
| June 30, 2024 | 42.91M |
| Date | Value |
|---|---|
| March 31, 2024 | 42.46M |
| December 31, 2023 | 42.20M |
| September 30, 2023 | 82.18M |
| June 30, 2023 | 81.55M |
| March 31, 2023 | 81.09M |
| December 31, 2022 | 82.10M |
| September 30, 2022 | -1.860M |
| June 30, 2022 | -1.672M |
| March 31, 2022 | 0.0137M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Scilex Holding Co. | -308.32M |
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.943M |
| Total Liabilities (Quarterly) | 31.62M |
| Debt to Equity Ratio | -0.7768 |
| Current Ratio | 0.1118 |
| Net Debt Paydown Yield | -3.50% |